Anavex Life Sciences Corp (AVXL)

[nidan7500]

“This should allow us to improve upon existing trial designs and expedite other aspects of our clinical development program.” '

Agree also. If this will all happen in my lifetime is an unknown but AVXL is clearly looking to only use trials as a method for verification of the upfront analysis proving it was completely and properly done. A massive learning process shift from old days which, we can all see now, was massively expensive and marginally effective. When he finally proves this technique is effective (as it must be) we will all be better off. Have to work on the timing thing.